Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation

Name: Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation
License: Public Domain

Ying Lin

ClinicalTrials.gov · Datasets · License: Public Domain

her-2 negative breast cancer, hrr gene mutation

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 651230
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.